The main mechanisms of chlorogenic acid in inhibiting atherosclerosis include increased synthesis and mRNA expression of PPARγ, LXRα, ABCA1 and ABCG1, as well as transcriptional activity resulting from PPARγ activation [47,48]. The gene discussed is PPARG; the disease is atherosclerosis.